Using RNA-seq to Identify Biomarkers for Guanylyl Cyclase C Activity by Hoeltzel, Gerard & Waldman, MD, PhD, Scott
Thomas Jefferson University 
Jefferson Digital Commons 
Phase 1 Class of 2023 
2-2021 
Using RNA-seq to Identify Biomarkers for Guanylyl Cyclase C 
Activity 
Gerard Hoeltzel 
Scott Waldman, MD, PhD 
Follow this and additional works at: https://jdc.jefferson.edu/si_ctr_2023_phase1 
 Part of the Translational Medical Research Commons 
Let us know how access to this document benefits you 
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital 
Commons is a service of Thomas Jefferson University's Center for Teaching and Learning (CTL). The Commons is 
a showcase for Jefferson books and journals, peer-reviewed scholarly publications, unique historical collections 
from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and interested 
readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been 
accepted for inclusion in Phase 1 by an authorized administrator of the Jefferson Digital Commons. For more 
information, please contact: JeffersonDigitalCommons@jefferson.edu. 
RNA-seq Analysis of GCC WT vs. KO Mice 
Gerard D. Hoeltzel, Scott Waldman MD PhD**
Introduction and Objective
• Colorectal cancer (CRC)
• 3rd most common dx. of malignancy 
• 2nd Deadliest Form of cancer 
• Immunotherapy has fallen short as potential 1st line treatment due 
to low microsatellite instability compared to other cancers 
• Need for additional therapies
• Guanylyl Cyclase C (GCC)
Transmembrane receptor of intestinal epithelial cells 
Regulates ‘crypt-villus’ axis
Waldman et al. (2009): GCC signaling reverses tumorigenic 
phenotype in CRC, consider CRC a disease of hormone insufficiency 
Waldman et al. (2011): GCC = tumor suppressor whose activation 
by guanylin and uroguanylin is necessary to limit cell cycle 
progression and maintain metabolic regulation 
Mice deficient in GCC → greater susceptibility to colon cancer
• My Objective:
• RNA-seq analysis to assess variations in gene expression 
between GCC WT and KO mice
• Identify genes and pathways whose activity may be linked 
with GCC pathway signaling
Research Question & Hypothesis
• Research Question
• Which genes and biochemical pathways have significant 
variations between mice with vs. without GCC expression?
• Hypothesis
• Exploratory research. Significant variations in gene products 
implicated in GCC signaling pathways will be observed between WT and 
KO mice. 
Approach
• Study design: Secondary Data Analysis
• RNA data from these cell lines has already been collected and 
sequenced
• Study Sample: RNA-seq data on 20,000 genes from 5 GCC WT Mice, 
5 GCC KO Mice
• Outcomes: log2 Fold Change of mRNA expression levels between 
the two samples for each gene of interest 
• Data source and collection: RNA-seq data obtained from third 
party sequencing of mice from Waldman lab
Results
• Goal: Identification of specific genes that are either known or 
unknown to contribute to the GCC signaling pathways
• Unexpected Results: Identified differentially expressed genes 
have no overlap with the GCC signaling pathway
Analysis:
1. Using R → identify genes with significant differences in mRNA 
expression levels
2. Use Gene Ontology database to cross reference identified gene 
products with known biochemical pathways to determine if 
differentially expressed genes belong to specific pathways 
implicated in GCC signaling
Results Continued
Results
• Boxplot comparing normalized RPKM expression levels across all twelve samples
• Visually, there doesn’t appear to be drastic differences between the sample 
groups in terms of average expression across all genes 
Results
Results • Blue = low expression levels in KO
• Red = high expression levels in KO
Results
Conclusions
1. More differences in gene expression levels of mice within
the same genotype category (unexpected result)
a) Warrants reconsideration of the mice used 
2. Code written in R was able to detect genetic differences
and properly identified that GCC had different expression 
levels between the two groups of mice
3. Lack of alignment with current literature given novelty of 
this experiment 
4. Personal Takeaway: learned how to use R to analyze 
datasets for clinical and translational 
Future Directions
1. Re-run analysis while ensuring identical genotypes
2. Improve methods of analysis on R to better identify 
additional genes of interest
3. Identify a better method of identifying pathways that 
incorporate the genes with varying differences
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